← Every company
BioMarin Pharmaceutical Inc SEC Filings
What BioMarin Pharmaceutical Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
BMRN overview →Filings on file
139
since Oct 27, 2016
Warning signs
0
none filed
Last results
Oct 6, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Sep 14, 2026 | Executive or director change 8-K | Read ↗ |
| Jun 4, 2026 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Dec 17, 2025 | Executive or director change 8-K | Read ↗ |
| Aug 11, 2025 | Executive or director change 8-K | Read ↗ |
| Aug 1, 2025 | Executive or director change 8-K | Read ↗ |
| May 22, 2025 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Feb 24, 2025 | Executive or director change 8-K | Read ↗ |
| Aug 22, 2024 | Executive or director change 8-K | Read ↗ |
| Jan 11, 2024 | Executive or director change 8-K | Read ↗ |
| Dec 20, 2023 | Executive or director changeMaterial agreement 8-K | Read ↗ |
| Nov 3, 2023 | Executive or director change 8-K | Read ↗ |
| May 30, 2023 | Executive or director changeShareholder vote 8-K | Read ↗ |
| May 5, 2022 | Executive or director change 8-K | Read ↗ |
| Dec 15, 2021 | Executive or director change 8-K | Read ↗ |
| Nov 3, 2021 | Executive or director change 8-K | Read ↗ |
| Jun 1, 2021 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Feb 22, 2021 | Executive or director change 8-K | Read ↗ |
| Jul 2, 2020 | Executive or director change 8-K | Read ↗ |
| Apr 22, 2020 | Executive or director change 8-K | Read ↗ |
| Feb 3, 2020 | Executive or director change 8-K | Read ↗ |
| Jul 10, 2019 | Executive or director change 8-K | Read ↗ |
| Jun 7, 2019 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Oct 3, 2017 | Executive or director change 8-K | Read ↗ |
| Jun 12, 2017 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Dec 19, 2016 | Executive or director changeMaterial agreement 8-K | Read ↗ |
| Dec 9, 2016 | Executive or director change 8-K | Read ↗ |
Source: BioMarin Pharmaceutical Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on BMRN
Company overviewEverything on BMRN in one place, with the price.Insider tradingWhat BMRN's own officers and directors buy and sell.Executive payWhat BMRN awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in BMRN.Funds holding itWhich funds and ETFs hold BMRN, and how big a bet.LobbyingWhat BMRN spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on BMRN's account, and who they worked for.PatentsWhat BMRN is filing at the patent office.